Portola Pharma (PTLA) Reports Q3 Loss of $1.64/Share

November 7, 2016 4:35 PM EST

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Portola Pharma (NASDAQ: PTLA) reported Q3 EPS of ($1.64), may not compare to the analyst estimate of ($1.10).

For earnings history and earnings-related data on Portola Pharma (PTLA) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment